No profile data available.
Incannex Healthcare Inc. (IXHL) is a healthcare company in the brain and nerve treatment drugs industry, based in Melbourne, Australia, with about 12 full-time employees.
In Q3 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $38.89 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.
$38.89 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Alterity Therapeutics Limited (ATHE), Annovis Bio, Inc. (ANVS), CervoMed Inc. (CRVO), Quince Therapeutics, Inc. (QNCX).